SightMD, a leading multi-specialty ophthalmology platform and a portfolio company of Chicago Pacific Founders announced the appointment of senior executive, Jonathan C. Lujan, to serve as its Chief Executive Officer.
Mr. Lujan is a tenured healthcare executive, with prior roles as the Chief Growth Officer of Surgical Information Systems, an investment banker in the Healthcare Investment Banking Group at JP Morgan Chase, and a director at GE Healthcare. Most recently, he successfully led Lifeline Vascular Care, a subsidiary of DaVita Inc., and a provider of care to patients suffering from end-stage renal disease and peripheral arterial disease with one of the largest networks of vascular access centers across the country. Mr. Lujan holds a Master of Business Administration from Harvard Business School, a Master of Science in Mechanical Engineering from Columbia University, and a Bachelor of Science in Management Information Systems from the University at Albany.
Mr. Lujan succeeds Jeffrey Martin, MD, FACS as the Company’s CEO. Dr. Martin, a Co-founder and President of SightMD, said, “We are thrilled to have the opportunity to partner with such a talented healthcare leader who embodies SightMD’s principles of clinically-excellent care, patient access, and rapid growth. Jonathan is a proven, results-oriented executive who will enable SightMD’s physicians to continue to focus our attention on providing patients with the high-quality personalized care they deserve.”
John Passarelli, MD, a Co-founder and Chairman of SightMD, remarked, “We are seeking to create the preeminent ophthalmology platform in the United States, and as such, ran a highly-competitive national search. Jonathan’s background, culture and vision very quickly separated him from others in the candidate pool. We could not be more excited to welcome him to the SightMD team.”
Mr. Lujan is a New York native who is passionate about improving patient care and the broader healthcare system. “I am honored to have the opportunity to partner with SightMD’s physicians and CPF at this exciting time in the Company’s evolution,” said Mr. Lujan. “Dr. Martin, Dr Passarelli and SightMD’s physician shareholders have done an excellent job creating a platform with limitless potential. I look forward to working collaboratively with them to realize this significant opportunity.”
About SightMD
SightMD is a rapidly-growing integrated ophthalmic provider group, offering patients access to over 50 ophthalmic surgeons and specialists through the convenience of 29 locations spanning the east end of Long Island to Manhattan. SightMD’s track record of providing clinically-excellent care spans over 50 years, and its services include laser cataract surgery and lens implantation, glaucoma management, retinal disorder treatment, corneal services, neuro-ophthalmology, LASIK laser vision correction, oculoplastic surgery, pediatric ophthalmology, and audiology. SightMD provides its physicians with world-class management services, including a 24/7 call center, billing, credentialing, human resources and other services, enabling them to continue delivering best-in-class care to patients in SightMD’s communities. SightMD is backed by Chicago Pacific Founders, a leading middle market private equity firm which focuses exclusively on partnerships with growing companies in the healthcare services sector. For more information about SightMD, please visit http://www.sightmd.com
